| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Other Original Articles |
John P. Robarts Research Institute (A.M., H.C., R.A.H.), London, Ontario, Canada N6A 5K8; Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto (B.Z., A.J.G.H.), Ontario, Canada M5G 1X5; Thames Valley Family Practice Research Unit, University of Western Ontario (S.B.H.), London, Ontario, Canada N6G 4X8; Department of Biochemistry and Molecular Biology, Merck Frosst Center for Therapeutic Research (B.P.K.), Pointe Claire-Dorval, Quebec, Canada H9R 4P8
Address all correspondence and requests for reprints to: Robert A. Hegele, M.D., Blackburn Cardiovascular Genetics Laboratory, Robarts Research Institute, 406-100 Perth Drive, London, Ontario, Canada N6A 5K8. E-mail: robert.hegele{at}rri.on.ca
Abstract
Several lines of evidence support a role for protein tyrosine phosphatase 1B (PTP-1B) in metabolism, and specifically in insulin sensitivity and obesity. We report the development of reagents for the amplification and sequencing of the PTP-1B gene, which has resulted in the identification of a novel single nucleotide polymorphism (SNP), designated 981C
T. We found a significant association between this SNP and the risk of either impaired glucose tolerance (IGT) or type 2 diabetes in the Oji-Cree of Sandy Lake, Ontario, Canada. Six hundred and fifty-three subjects were genotyped using PCR amplification of exon 8, followed by digestion with the restriction enzyme AvaI. Sixty-eight subjects were heterozygotes, and none was a homozygote. Thus, the overall frequencies of the C allele and the T allele were 0.948 and 0.052, respectively. Subjects with the PTP-1B 981T/981C genotype were approximately 40% less likely to have IGT or diabetes as subjects with the 981C/981C genotype (P = 0.040). There was no difference in quantitative traits among subjects grouped according to the PTP-1B 981C
T SNP genotype. These very preliminary findings suggest that genomic variation in PTP-1B is associated with a reduced risk of diabetes and are consistent with the idea that this protein is important in metabolism.
This article has been cited by other articles:
![]() |
R. Meshkani, M. Taghikhani, H. Al-Kateb, B. Larijani, S. Khatami, G. K. Sidiropoulos, R. A. Hegele, and K. Adeli Polymorphisms within the Protein Tyrosine Phosphatase 1B (PTPN1) Gene Promoter: Functional Characterization and Association with Type 2 Diabetes and Related Metabolic Traits Clin. Chem., September 1, 2007; 53(9): 1585 - 1592. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. Burdon, J. L. Bento, C. D. Langefeld, J. K. Campbell, J. J. Carr, L. M. Wagenknecht, D. M. Herrington, B. I. Freedman, S. S. Rich, and D. W. Bowden Association of Protein Tyrosine Phosphatase-N1 Polymorphisms With Coronary Calcified Plaque in the Diabetes Heart Study Diabetes, March 1, 2006; 55(3): 651 - 658. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Spencer-Jones, X. Wang, H. Snieder, T. D. Spector, N. D. Carter, and S. D. O'Dell Protein Tyrosine Phosphatase-1B Gene PTPN1: Selection of Tagging Single Nucleotide Polymorphisms and Association With Body Fat, Insulin Sensitivity, and the Metabolic Syndrome in a Normal Female Population Diabetes, November 1, 2005; 54(11): 3296 - 3304. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Qiu, R. K. Avramoglu, N. Dube, T. M. Chong, M. Naples, C. Au, K. G. Sidiropoulos, G. F. Lewis, J. S. Cohn, M. L. Tremblay, et al. Hepatic PTP-1B Expression Regulates the Assembly and Secretion of Apolipoprotein B-Containing Lipoproteins: Evidence From Protein Tyrosine Phosphatase-1B Overexpression, Knockout, and RNAi Studies Diabetes, December 1, 2004; 53(12): 3057 - 3066. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Bento, N. D. Palmer, J. C. Mychaleckyj, L. A. Lange, C. D. Langefeld, S. S. Rich, B. I. Freedman, and D. W. Bowden Association of Protein Tyrosine Phosphatase 1B Gene Polymorphisms With Type 2 Diabetes Diabetes, November 1, 2004; 53(11): 3007 - 3012. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Palmer, J. L. Bento, J. C. Mychaleckyj, C. D. Langefeld, J. K. Campbell, J. M. Norris, S. M. Haffner, R. N. Bergman, and D. W. Bowden Association of Protein Tyrosine Phosphatase 1B Gene Polymorphisms With Measures of Glucose Homeostasis in Hispanic Americans: The Insulin Resistance Atherosclerosis Study (IRAS) Family Study Diabetes, November 1, 2004; 53(11): 3013 - 3019. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Olivier, C. A. Hsiung, L.-M. Chuang, L.-T. Ho, C.-T. Ting, V. I. Bustos, T. M. Lee, A. de Witte, Y.-D. I. Chen, R. Olshen, et al. Single nucleotide polymorphisms in protein tyrosine phosphatase 1{beta} (PTPN1) are associated with essential hypertension and obesity Hum. Mol. Genet., September 1, 2004; 13(17): 1885 - 1892. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Z. Al-Shali, A. A. House, A. J.G. Hanley, H. M.R. Khan, S. B. Harris, B. Zinman, M. Mamakeesick, A. Fenster, J. D. Spence, and R. A. Hegele Genetic Variation in PPARG Encoding Peroxisome Proliferator-Activated Receptor {gamma} Associated With Carotid Atherosclerosis Stroke, September 1, 2004; 35(9): 2036 - 2040. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Zabolotny, F. G. Haj, Y.-B. Kim, H.-J. Kim, G. I. Shulman, J. K. Kim, B. G. Neel, and B. B. Kahn Transgenic Overexpression of Protein-tyrosine Phosphatase 1B in Muscle Causes Insulin Resistance, but Overexpression with Leukocyte Antigen-related Phosphatase Does Not Additively Impair Insulin Action J. Biol. Chem., June 4, 2004; 279(23): 24844 - 24851. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. San Millan, M. Corton, G. Villuendas, J. Sancho, B. Peral, and H. F. Escobar-Morreale Association of the Polycystic Ovary Syndrome with Genomic Variants Related to Insulin Resistance, Type 2 Diabetes Mellitus, and Obesity J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2640 - 2646. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. ANDERSEN, P. G. JANSEN, S. M. ECHWALD, O. H. MORTENSEN, T. FUKADA, R. DEL VECCHIO, N. K. TONKS, and N. P. H. MOLLER A genomic perspective on protein tyrosine phosphatases: gene structure, pseudogenes, and genetic disease linkage FASEB J, January 1, 2004; 18(1): 8 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Asante-Appiah and B. P. Kennedy Protein tyrosine phosphatases: the quest for negative regulators of insulin action Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E663 - E670. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |